3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
58
Carcinoma, Non-Small-Cell Lung
34
Urinary Bladder Neoplasms
29
Neoplasm Metastasis
20
Lung Neoplasms
19
Ovarian Neoplasms
18
Lymphoma, Large B-Cell, Diffuse
18
Cholangiocarcinoma
16
Biliary Tract Neoplasms
14
Triple Negative Breast Neoplasms
13
Neoplasms
13
Nasopharyngeal Carcinoma
13
Colorectal Neoplasms
12
Breast Neoplasms
12
Carcinoma, Transitional Cell
11
Non-Muscle Invasive Bladder Neoplasms
10
Recurrence
9
Fallopian Tube Neoplasms
9
Gallbladder Neoplasms
8
Sarcoma
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Bile Duct Neoplasms
6
Osteosarcoma
5
Lymphoma, Non-Hodgkin
5
Lymphoma
5
Endometrial Neoplasms
5
Uterine Cervical Neoplasms
4
Melanoma
4
Lymphoma, T-Cell, Peripheral
4
Hodgkin Disease
4
Interventions
Magnetic Resonance Spectroscopy
15
Specimen Handling
12
Cisplatin
9
Platinum
7
1,2-diaminocyclohexaneplatinum II citrate
7
pembrolizumab
6
Radiotherapy, Intensity-Modulated
6
Cetuximab
6
Biopsy
6
Radiation
5
Carboplatin
5
Radiotherapy
4
(225)Ac-DOTA-c(RGDyK)
4
cemiplimab
3
X-Rays
3
Taxes
3
Standard of Care
3
Paclitaxel
3
Immunoglobulin G
3
Disulfides
3
ipatasertib
2
Ultrasonography
2
Practice Guidelines as Topic
2
Nivolumab
2
Interviews as Topic
2
Fluorodeoxyglucose F18
2
Drug Therapy
2
Docetaxel
2
Bevacizumab
2
trastuzumab deruxtecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mouth Neoplasms
×
Gemcitabine
×
90 days
×
Clear all
No trials found.